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Effects of Subanesthetic
Concentrations of Enflurane on
Rat Pregnancy and Early Development
by C. Denny Strout,* Michael L. Nahrwold,*
Margaret D. Taylor,* and Ian S. Zagon*
Anesthetic pollutants in the operating room have been implicated in producing spontaneous abortion in
exposed personnel and congenital malformations among their offspring. To test the effects of trace
concentrations of enflurane on pregnancy, rats were exposed to two levels (10.7 and 63.7 ppm) of the
anesthetic for 8 hr daily from days 1 to 19ofpregnancy. Litter sizes were not affected but birth weights of
exposed offspring were slightiy higher than controls. During lactation, cross-fostering studies were per-
formed. Exposed offspring were housed with nonexposed mothers and vice versa to determine ifexposure
during pregnancy affected early development. Weights at 7, 14, and 21 days ofage did not differ among
the offspring in the lower dose experiment. Weights ofthe cross-fostered groups in the high dose experi-
ment were decreased at day seven compared to controls. In the same experiment, exposed offspring
housed with exposed mothers were heavier than controls on day 21 of lactation. The modest nature of
these alterations suggests that enflurane has littie or no gross effect on rat pregnancy and postnatal
development.
The effects of anesthetic pollutants on operating
room personnel have been the subject of increasing
interest as set forth in a recent review (1). Trace
levels of anesthetics have been implicated in pro-
ducing an increased incidence ofcancer (2, 3), liver
disease, and kidney disease (2). A potential hazard
ofgreat concern involves chronic exposure to trace
anesthetics during pregnancy. An increased inci-
dence of spontaneous abortion among anesthetists
and other operating room personnel has been re-
ported by several authors (2, 4-7). However, a
cause-effect relationship has not been established
and there is some evidence that factors other than
anesthetics, such as stress (7), may be responsible.
Nevertheless, there have been reports of an in-
crease in the incidence ofcongenital malformations
among the offspring of anesthetists (2, 6, 8).
Although embryolethality has been demonstrated
in laboratory animals exposed to high concentra-
tions of anesthetics (9-11), there is little evidence
that levels commonly found in the operating room
are also embryolethal. Corbett et al. reported an
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increased incidence of fetal deaths in rats exposed
to 1,000 and 15,000 ppm ofnitrous oxide during the
mid and late gestation periods (12). However, 100
ppm did not have a significant effect. Bruce showed
that exposure of mice to 16 ppm of halothane prior
to and during pregnancy neither affected fertility of
males or females nor did it affect the outcome of
pregnancy (13). Similar findings were reported by
Wharton et al. in mice exposed to 500 and 1000 ppm
of halothane (14). Corbett et al. found no em-
bryolethality for 100 ppm of halothane or 100 ppm
plus 0.5% nitrous oxide in rats exposed during mid-
pregnancy (15).
In recent years, enflurane (2-chloro-1,1,2-tri-
fluoroethyl difluoromethyl ether), a volatile anes-
thetic, has gained popularity in this country. There
have been no published reports to date on the ef-
fects of trace levels of this agent on pregnancy.
Therefore, we have exposed pregnant rats to two
concentrations of this anesthetic under simulated
operating room conditions. Weight gain of the
mothers during pregnancy, litter size, and birth
weight of the offspring were utilized as indices of
fetal development. Weight gain of the pups in
cross-fostering experiments was measured in an ef-
fort to detect developmental abnormalities.
211Methods
Female, virgin Sprague-Dawley rats of the same
approximate age and weight were obtained from
Charles River Breeders and mated. Day 1 of preg-
nancy was diagnosed with the presence of vaginal
sperm. The animals were then randomly assigned to
either an experimental or a control group. Two ex-
periments were performed, with low and high dose
enflurane exposure for 8 hr/day (8:00 a.m. to 4:00
p.m.) from day I to day 19 of pregnancy. A diurnal
cycle of alternating 12-hr periods of light and dark
was maintained, with exposure occurring during the
light period.
During the exposure period the rats were housed,
five to six animals per cage, in standard 38 x 46 x
20 cm mesh-bottom cages and provided with free
access to food and water. Isolation cubicles
measuring 1.83 x 3.15 x 1.22 m and constructed of
painted cinderblock with sliding Plexiglas front
panels served as the exposure chambers. The con-
trol and experimental cubicles were identical but in
separate rooms. Room air, which had been filtered
through Fiberglass and charcoal, was drawn
through the bottom of the cubicle and exhausted
through the top to provide an air turnover rate of 18
cycles/hr. This was adequate to maintain carbon
dioxide at less than 0.1% as measured by infrared
analysis, and oxygen at normal ambient levels as
measured by paramagnetic analysis. Enflurane was
delivered into the experimental chamber in filtered
compressed air via a Drager vaporizer. Air samples
were withdrawn from each cage several times daily
via Teflon tubing and analyzed for enflurane con-
centration by gas chromatography. Temperature
and humidity within the cubicle were similarly mon-
itored. Figures 1 and 2 show the conditions within
the cubicles on a daily basis for each of the experi-
ments. During the low-dose experiment, mean en-
flurane concentration was 10.7 ppm (S.D. = 1.4),
while in the high-dose experiment it was 63.7 ppm
(S.D. = 13.6). All animals were weighed every
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FIGURE 1. Cubicle conditions (low dose).
other day. No differences were noted in the pattern
ofweight gain, feeding habits, behavior, or appear-
ance between the experimental and control groups.
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FIGURE 2. Cubicle conditions (high dose).
At the end ofthe nineteenth day ofgestation, the
rats were removed from the cubicles and placed
individually in solid bottom cages to deliver their
offspring. The day of gestation on which birth had
occurred, total number of live births, and the birth
weights of the young were recorded. The uteri of
those animals which did not deliver were examined.
None showed signs of pregnancy and those rats
were eliminated from the study.
During lactation, a cross-fostering study was
performed for both the low- and high-dose experi-
ments. Each of three experimental (enflurane-
exposed) mothers were caged separately with eight
control (nonexposed) offspring, and each of three
control mothers were caged with eight experimental
offspring. In addition, three each of the experimen-
tal and control mothers were caged with eight off-
spring of their own group. Weights of the offspring
were recorded at 7, 14, and 21 days of age.
Results
The mean weight of mothers in the control and
experimental groups did not differ at day 1 or day 19
ofgestation during both the low-dose and high-dose
experiments (Table 1). Similarly, control and ex-
perimental litter sizes did not differ in either exper-
iment (Table 2). Birth weights ofenflurane-exposed
offspring were slightly higher than the nonexposed
controls in each ofthe two experiments (Table 3).
There were no weight differences among the
offspring during lactation in the low-dose study at 7,
14, and 21 days (Table 4). However, in the high-
dose experiment, the two cross-fostered groups
weighed less at 7 days when compared to control
mothers with control offspring (Table 5). These dif-
ferences were not apparent at 14 days. However, at
21 days experimental pups housed with experimen-
tal mothers weighed significantly more than control
mothers housed with control offspring.
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Day Mean weight + SD, g
of
gestation Experiment Control Experimental
I Low dose 209 + 4.9 203 ± 7.7a
(n =9) (n =9)
19 Low dose 323 ± 7.4 317 ± 10.0°
(n =9) (n =9)
I High dose 214 ± 14.5 208 ± 18.9a
(n =6) (n =13)
19 High dose 334 ± 18.9 330 ± 33.9a
(n =6) (n= 13)
'No different from control by Student's t-test for unpaired
data.
Table 2. Litter size.
Mean litter size + SD
(range) Number of litters
Experiment Control Experimental Control Experimental
Low dose 13.8 + 2.1 11.7 + 2.3a 9 9
(11-17) (6_14)b
High dose 11.7 + 1.0 11.5 + 1.90 6 13
(10-13) (7-14)
'No different from control by Student's t-test for unpaired data.
bRange is 11-14 excluding one litter of 6.
Table 3. Birth weights ofoffspring.
Experiment Group Mean weight ± SD, g n
Low dose Control 5.93 ± 0.39 124
Low dose Experimental 6.18 ± 0.51* 105
High dose Control 6.53 + 0.61 70
High dose Experimental 6.74 ± 0.74* 150
aDiffers from control, p < 0.01, by Student's t-test for
unpaired data.
Discussion
An attempt was made to simulate the operating
room environment and the conditions under which
operating room personnel are exposed to anesthet-
ics. The two doses of enflurane were chosen to ap-
proximate the range of values commonly measured
in the area ofthe anesthetist in our operating room.
A daily 8-hr exposure. period was chosen to simu-
late a normal working day. Enflurane exposure was
started on day I of gestation so that any early ef-
fects on pregnancy would be detected.
Our data suggest that enflurane, in the concentra-
tions tested, has little or no gross effect on either rat
pregnancy or early postnatal development. The
smallest litter among the exposed rats was six
offspring. Examination of the uterus of this rat re-
vealed placental scars in only one horn ofthe bicor-
nuate uterus. This may have been due to an isolated
anatomical defect. The differences found in the
birth weights could reflect a modest anesthetic ef-
fect or a variation in gestational age. The weight
decrement found at day seven in both cross-
fostered groups ofthe high-dose experiment did not
persist to day fourteen. Exposed offspring fostered
by exposed mothers actually weighed more than
controls on day 21 in the same experiment. There-
fore, it is difficult to postulate either maternal or
fetal effects of subanesthetic enflurane exposure
from these findings.
We conclude that, under the conditions of this
experiment, enflurane has no gross effects on rat
pregnancy or early postnatal development.
Table 4. Weights ofoffspring during lactation: low-dose experiment.
Groups Meanweights ± SD, g
Mothers Offspring 7 days 14 days 21 days
Control Control 16.0 + 0.9 30.1 + 1.3 45.8 ± 3.3
(n =24) (n = 24) (n = 24)
Control Experimental 15.2 + 1.3 29.0 ± 2.4 44.8 t 4.2
(n =24) (n = 23) (n = 23)
Experimental Control 15.7 ± 1.3 30.6 ± 2.4 45.2 + 4.0
(n = 24) (n = 22) (n = 22)
Experimental Experimental 15.7 t 2.9 28.4 + 5.8 45.4 ± 8.3
(n = 24) (n = 24) (n = 24)
Table 5. Weights ofoffspring during lactation: high dose experiment.
Groups Mean weights ± SD, g
Mothers Offspning 7 days 14 days 21 days
Control Control 18.9 ±1.0 34.6 ± 1.8 52.7 ± 7.6
(n = 24) (n = 24) (n = 24)
Control Experimental 16.3 ± 2.1a 34.7 ± 4.1 55.4 ± 8.3
(n =24) (n =24) (n =24)
Experimental Control 16.9 ± 2.6* 33.4 ± 4.4 54.6 ± 7.4
(n =24) (n = 24) (n =24)
Experimental Experimental 18.1 ± 1.9 34.8 ± 2.4 59.9 ± 4.6*
(n = 24) (n = 24) (n = 24)
aDifferent from control mothers with control offspring (p < 0.01) when tested with analysis of variance followed by
Dunnett's procedure (16).
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